跳至主要内容
临床试验/JPRN-UMIN000005600
JPRN-UMIN000005600已完成未知

Feasibility stuydy of S-1 and weekly cisplatin in patients received R0 resection for Stage IIB and III gastric cancer - Feasibility study of S-1 and weekly cisplatin in patients recieved R0 resection gastric cancer.

Hamamatsu Organization for Oncology Research and Education : HORE0 个研究点目标入组 40 人开始时间: 2011年5月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) synchronous or metachronous (within 5 years) malignancy other than carcinoma in situ 2) administration contraindication to S-1 and CDDP 3) systemic administration of corticosteroids, flucytosine, phenytoin or warfarin 4) with active infection 5) with drug hypersensitivity 6) other severe complications, such as paralytic ileus, bowel obstruction, interstitial pneumonitis, pulmonary fibrosis, regular use of insulin or uncontrollable diabetes mellitus, arrhythmias, heart failure, liver cirrhosis, and active hepatitis) 7) with water solubility diarrhea 8) pregnant or lactating women, women who are capable of pregnancy or intend to get pregnant 9) men with willing to get pregnant 10)Any other cases who are regarded as inadequate for study enrollment by the investigator

研究者

发起方
Hamamatsu Organization for Oncology Research and Education : HORE

相似试验